BioAtla Debt-to-Equity Ratio Growth & History (BCAB)
BioAtla's debt-to-equity ratio was 0.06 for fiscal 2024.
View full BioAtla company overviewBioAtla annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.06 | 0.02 | +68.36% |
| 2023 | 2023-12-31 | 0.03 | 0.01 | +57.64% |
| 2022 | 2022-12-31 | 0.02 | −0.00 | −13.33% |
| 2021 | 2021-12-31 | 0.03 | 0.03 | — |
| 2020 | 2020-12-31 | 0.00 | — | — |
BioAtla quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | 1.01 | 0.97 | +2517.06% |
| Q4 2024 | 2024-12-31 | 0.06 | 0.02 | +68.36% |
| Q3 2024 | 2024-09-30 | 0.05 | 0.02 | +81.18% |
| Q2 2024 | 2024-06-30 | 0.05 | 0.03 | +104.11% |
| Q1 2024 | 2024-03-31 | 0.04 | 0.02 | +67.79% |
| Q4 2023 | 2023-12-31 | 0.03 | 0.01 | +57.64% |
| Q3 2023 | 2023-09-30 | 0.03 | −0.00 | −1.31% |
| Q2 2023 | 2023-06-30 | 0.03 | −0.00 | −9.02% |
| Q1 2023 | 2023-03-31 | 0.02 | −0.00 | −13.02% |
| Q4 2022 | 2022-12-31 | 0.02 | −0.00 | −13.33% |
| Q3 2022 | 2022-09-30 | 0.03 | 0.03 | — |
| Q2 2022 | 2022-06-30 | 0.03 | 0.03 | — |
| Q1 2022 | 2022-03-31 | 0.03 | 0.03 | — |
| Q4 2021 | 2021-12-31 | 0.03 | 0.03 | — |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
| Q2 2021 | 2021-06-30 | 0.00 | — | — |
| Q1 2021 | 2021-03-31 | 0.00 | — | — |
| Q4 2020 | 2020-12-31 | 0.00 | — | — |
BioAtla debt-to-equity ratio trends
Between the periods ended 2020-12-31 and 2024-12-31, BioAtla's debt-to-equity ratio increased from 0.00 to 0.06, a change of 0.06. The latest reported quarter, Q1 2025, shows 1.01.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioAtla source filings ↗